$15.04
-0.55-3.53%
At Close: -
$15.04
00.00%
After Hours: Jul 19, 7:57 PM EDT
15 minutes delayed
Comments
Loading...
Bilibili
BILINASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Bilibili (NASDAQ:BILI) Stock, Analyst Ratings, Price Targets, Forecasts
Bilibili Inc has a consensus price target of $33.52 based on the ratings of 17 analysts. The high is $120 issued by Baird on August 18, 2023. The low is $12.5 issued by Citigroup on March 11, 2024. The 3 most-recent analyst ratings were released by JP Morgan, UBS, and Benchmark on June 18, 2024, May 31, 2024, and May 24, 2024, respectively. With an average price target of $18.33 between JP Morgan, UBS, and Benchmark, there's an implied 21.90% upside for Bilibili Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
UBS
Benchmark
Barclays
CLSA
1calculated from analyst ratings
Analyst Ratings for Bilibili
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/18/2024 | Buy Now | 39.63% | JP Morgan | Daniel Chen | → $21 | Upgrade | Neutral → Overweight | Get Alert |
| 05/31/2024 | Buy Now | 19.68% | UBS | Felix Liu | $11.9 → $18 | Upgrade | Neutral → Buy | Get Alert |
| 05/24/2024 | Buy Now | 6.38% | Benchmark | Fawne Jiang | $15 → $16 | Maintains | Buy | Get Alert |
| 05/24/2024 | Buy Now | -6.91% | Barclays | Jiong Shao | $10 → $14 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 11.7% | CLSA | Elinor Leung | $12.2 → $16.8 | Upgrade | Outperform → Buy | Get Alert |
| 05/10/2024 | Buy Now | 13.03% | Mizuho | James Lee | $15 → $17 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | -16.89% | Citigroup | Brian Gong | $18 → $12.5 | Downgrade | Buy → Neutral | Get Alert |
| 03/11/2024 | Buy Now | -26.86% | JP Morgan | Daniel Chen | $10 → $11 | Upgrade | Underweight → Neutral | Get Alert |
| 03/08/2024 | Buy Now | -0.27% | Benchmark | Fawne Jiang | $21 → $15 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | -0.27% | Mizuho | James Lee | $16 → $15 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 6.38% | Mizuho | James Lee | $18 → $16 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | -12.23% | UBS | Felix Liu | $22 → $13.2 | Downgrade | Buy → Neutral | Get Alert |
| 11/30/2023 | Buy Now | 39.63% | Benchmark | Fawne Jiang | $35 → $21 | Maintains | Buy | Get Alert |
| 11/30/2023 | Buy Now | 3.72% | Goldman Sachs | Lincoln Kong | $17.4 → $15.6 | Maintains | Neutral | Get Alert |
| 11/30/2023 | Buy Now | -33.51% | Barclays | Jiong Shao | $15 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/12/2023 | Buy Now | 15.69% | Goldman Sachs | Lincoln Kong | $19.6 → $17.4 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | -0.27% | Barclays | Jiong Shao | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/18/2023 | Buy Now | 46.28% | UBS | Felix Liu | $23 → $22 | Maintains | Buy | Get Alert |
| 08/18/2023 | Buy Now | 132.71% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | Buy Now | 697.87% | Baird | David Koning | $140 → $120 | Maintains | Neutral | Get Alert |
| 07/27/2023 | Buy Now | -13.56% | JP Morgan | Daniel Chen | → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/25/2023 | Buy Now | 6.38% | HSBC | Charlotte Wei | $17 → $16 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | 52.93% | UBS | Felix Liu | $35 → $23 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 132.71% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 132.71% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 66.22% | B of A Securities | Brad Sills | $28 → $25 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | 59.57% | Citigroup | Brian Gong | $28 → $24 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | 13.03% | HSBC | Charlotte Wei | $22 → $17 | Maintains | Hold | Get Alert |
| 03/03/2023 | Buy Now | 132.71% | Benchmark | Jason English | → $35 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 86.17% | Citigroup | Brian Gong | → $28 | Upgrade | Neutral → Buy | Get Alert |
| 01/09/2023 | Buy Now | 68.22% | Goldman Sachs | Lincoln Kong | $22.2 → $25.3 | Maintains | Neutral | Get Alert |
| 11/30/2022 | Buy Now | 47.61% | Goldman Sachs | Lincoln Kong | $25.6 → $22.2 | Maintains | Neutral | Get Alert |
| 11/30/2022 | Buy Now | 6.38% | Barclays | Jiong Shao | $13 → $16 | Maintains | Equal-Weight | Get Alert |
| 11/03/2022 | Buy Now | -23.54% | B of A Securities | Brad Sills | $42 → $11.5 | Downgrade | Buy → Neutral | Get Alert |
| 10/28/2022 | Buy Now | -13.56% | Barclays | Jiong Shao | $21 → $13 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | Buy Now | -20.21% | Citigroup | Brian Gong | $38 → $12 | Downgrade | Buy → Neutral | Get Alert |
| 10/25/2022 | Buy Now | 32.98% | JP Morgan | — | $30 → $20 | Maintains | Overweight | Get Alert |
| 09/09/2022 | Buy Now | 99.47% | Benchmark | Fawne Jiang | $56 → $30 | Maintains | Buy | Get Alert |
| 09/09/2022 | Buy Now | 99.47% | UBS | Felix Liu | $40 → $30 | Maintains | Buy | Get Alert |
| 09/09/2022 | Buy Now | 39.63% | Barclays | Jiong Shao | $26 → $21 | Maintains | Equal-Weight | Get Alert |
| 09/07/2022 | Buy Now | — | JP Morgan | Daniel Chen | — | Assumes | → Overweight | Get Alert |
| 06/13/2022 | Buy Now | 66.22% | JP Morgan | Alex Yao | $19 → $25 | Maintains | Neutral | Get Alert |
| 06/10/2022 | Buy Now | 199.2% | Citigroup | Brian Gong | $46 → $45 | Maintains | Buy | Get Alert |
| 06/10/2022 | Buy Now | 72.87% | Barclays | Jiong Shao | $24 → $26 | Maintains | Equal-Weight | Get Alert |
| 05/25/2022 | Buy Now | 68.22% | CLSA | Elinor Leung | $33.4 → $25.3 | Maintains | Outperform | Get Alert |
| 05/16/2022 | Buy Now | 26.33% | JP Morgan | Alex Yao | $15 → $19 | Upgrade | Underweight → Neutral | Get Alert |
| 05/03/2022 | Buy Now | 59.57% | Barclays | Jiong Shao | $32 → $24 | Maintains | Equal-Weight | Get Alert |
| 03/14/2022 | Buy Now | -0.27% | JP Morgan | Alex Yao | → $15 | Downgrade | Overweight → Underweight | Get Alert |
| 03/04/2022 | Buy Now | 398.67% | Benchmark | Fawne Jiang | $86 → $75 | Maintains | Buy | Get Alert |
| 02/18/2022 | Buy Now | 185.9% | Goldman Sachs | Piyush Mubayi | $105 → $43 | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2022 | Buy Now | 112.77% | Barclays | Jiong Shao | → $32 | Initiates | → Equal-Weight | Get Alert |
| 01/11/2022 | Buy Now | 199.2% | Bernstein | Robin Zhu | → $45 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/28/2021 | Buy Now | 471.81% | Benchmark | Fawne Jiang | → $86 | Initiates | → Buy | Get Alert |
| 08/20/2021 | Buy Now | 744.41% | HSBC | Charlotte Wei | — | Maintains | Buy | Get Alert |
| 08/13/2021 | Buy Now | 631.38% | Deutsche Bank | Leo Chiang | — | Initiates | → Buy | Get Alert |
| 07/26/2021 | Buy Now | 657.98% | CLSA | Elinor Leung | — | Downgrade | Buy → Outperform | Get Alert |
| 07/23/2021 | Buy Now | 830.85% | HSBC | Charlotte Wei | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Bilibili (BILI) stock?
The latest price target for Bilibili (NASDAQ:BILI) was reported by JP Morgan on June 18, 2024. The analyst firm set a price target for $21.00 expecting BILI to rise to within 12 months (a possible 39.63% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bilibili (BILI)?
The latest analyst rating for Bilibili (NASDAQ:BILI) was provided by JP Morgan, and Bilibili upgraded their overweight rating.
When was the last upgrade for Bilibili (BILI)?
The last upgrade for Bilibili Inc happened on June 18, 2024 when JP Morgan raised their price target to $21. JP Morgan previously had a neutral for Bilibili Inc.
When was the last downgrade for Bilibili (BILI)?
The last downgrade for Bilibili Inc happened on March 11, 2024 when Citigroup changed their price target from $18 to $12.5 for Bilibili Inc.
When is the next analyst rating going to be posted or updated for Bilibili (BILI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bilibili, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bilibili was filed on June 18, 2024 so you should expect the next rating to be made available sometime around June 18, 2025.
Is the Analyst Rating Bilibili (BILI) correct?
While ratings are subjective and will change, the latest Bilibili (BILI) rating was a upgraded with a price target of $0.00 to $21.00. The current price Bilibili (BILI) is trading at is $15.04, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.